Prehospital stability of diazepam and lorazepam

被引:36
作者
Gottwald, MD [1 ]
Akers, LC [1 ]
Liu, PK [1 ]
Orsulak, PJ [1 ]
Corry, MD [1 ]
Bacchetti, P [1 ]
Fields, SM [1 ]
Lowenstein, DH [1 ]
Alldredge, BK [1 ]
机构
[1] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA
关键词
diazepam; lorazepam; status epilepticus; prehospital treatment;
D O I
10.1016/S0735-6757(99)90079-7
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Injectable benzodiazepines are commonly stocked on ambulances for use by paramedics, We evaluated the stability of lorazepam and diazepam as a function of storage temperature, Diazepam (5 mg/mL) and lorazepam (2 mg/mL) injectable solutions were stored for up to 210 days in clear glass syringes at three conditions: 4 degrees C to 10 degrees C (refrigerated); 15 degrees C to 30 degrees C (on ambulance ambient temperature); and 37 degrees C (oven-heated), High performance liquid chromatography (HPLC) analyses of syringe contents were performed at 30-day intervals, After 210 days, the reduction in diazepam concentration was 7% refrigerated, 15% at ambient temperature, and 25% at 37 degrees C, The reduction in lorazepam concentration was 0% refrigerated, 10% at ambient temperature, and 75% at 37 degrees C, Whereas diazepam retained 90% of its original concentration for 30 days of on ambulance storage, lorazepam retained 90% of its original concentration for 150 days. The decrease in lorazepam concentration correlated with an increase in the maximum ambient temperature in San Francisco. These results suggest that diazepam and lorazepam can be stored on ambulances, When ambient storage temperatures are 30 degrees C or less, ambulances carrying lorazepam and diazepam should be restocked every 30 to 60 days. When drug storage temperatures exceed 30 degrees C, more frequent stocking or refrigeration is required. Copyright (C) 1999 by W.B. Saunders Company.
引用
收藏
页码:333 / 337
页数:5
相关论文
共 13 条
  • [1] Barlow R. E., 1972, STAT INFERENCE ORDER
  • [2] DODSON WE, 1993, JAMA-J AM MED ASSOC, V270, P854
  • [3] EGAN JM, 1986, CHROMOBIO, V3124, P196
  • [4] FYLLINGEN G, 1991, PHARM ACTA HELV, V66, P44
  • [5] *HOFF ROCH INC, 1993, DIAZ VAL PACK INS
  • [6] EXTENSION OF EXPIRATION TIME FOR LORAZEPAM INJECTION AT ROOM-TEMPERATURE
    JAHNS, BE
    BAKST, CM
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (06): : 1134 - 1134
  • [7] MANCANO MA, 1995, AJHP, V552, P2213
  • [8] STABILITY OF LORAZEPAM DILUTED IN BACTERIOSTATIC WATER FOR INJECTION AT 2 TEMPERATURES
    NAHATA, MC
    MOROSCO, RS
    HIPPLE, TF
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1993, 18 (01) : 69 - 71
  • [9] Rutgers J G, 1980, ANAL PROFILES DRUGS, V9, P397
  • [10] *SAS I INC, 1996, SAS STAT SOFTW CHANG, P531